Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 4,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Gingival Recession
Interventions: VISTA, STA; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 99 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Diffuse Large B Cell Lymphoma, Lymphoma, Non-Hodgkin
Interventions: Doxil, Cyclophosphamide, Vincristine, Prednisone, Rituximab, Pegfilgrastim; Drug
Lead sponsor: The Alvin and Lois Lapidus Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 2
States / cities: Baltimore, Maryland • Randallstown, Maryland

Conditions: Postoperative Nausea and Vomiting
Interventions: TIVA NoNarc; Drug
Lead sponsor: Coastal Anesthesiology Consultants; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Saint Augustine, Florida

Conditions: Bladder Cancer
Interventions: cisplatin, doxorubicin hydrochloride, methotrexate, vinblastine; Drug
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: Up to 120 Years
Enrollment: 521 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2014
U.S. locations: 73
States / cities: Glendale, Arizona • Phoenix, Arizona • Los Angeles, California + 47 more

Conditions: Morbid Obesity
Interventions: propofol; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Limit Emergence Phenomena After General Anesthesia
Interventions: Induction of anesthesia, Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask], Laryngoscopy and placement of ETT, Ventilation via the ETT, Removal of the ETT, Intubation of the trachea through the LMA, Ventilation via the LMA, Emergence from anesthesia; Procedure · Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Systemic Lupus Erythematosus
Interventions: Placebo, Epratuzumab; Drug
Lead sponsor: UCB Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 791 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 49
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Hemet, California + 44 more

Conditions: Sport-related Concussion, Brain Concussion, Healthy
Interventions: high-intensity neck strengthening, Control group; Other
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 19 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Post-operative Vomiting
Interventions: Apple Juice, Water; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 2 Years to 18 Years
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Conditions Influencing Health Status, Social Determinants of Health
Interventions: Health Advocates Program, 211 Information Sheet; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 1,278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Liver Cancer
Interventions: TriNav, Traditional Delivery, Doxorubicin; Device · Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: COPD (Chronic Obstructive Pulmonary Disease)
Interventions: COPD Wellness, COPD Wellness Plus+, Usual Care; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 90 Years
Enrollment: 387 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: San Francisco, California

Conditions: Hepatocellular Carcinoma
Interventions: LC Bead loaded with doxorubicin; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Autism Spectrum Disorder, Mitochondrial Pathology, Epilepsy, Brain Tumor, Psychiatric Disorder, Mitochondrial Diseases
Interventions: Not listed
Lead sponsor: Southwest Autism Research & Resource Center; Other
Eligibility: Up to 18 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Phoenix, Arizona • Brooklyn, New York

Conditions: Injuries, Patellofemoral Pain Syndrome, Iliotibial Band Syndrome
Interventions: Strength and Coordination Training, Walking; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Triple Negative Breast Cancer
Interventions: urine collection; Other
Lead sponsor: George Washington University; Other
Eligibility: 21 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Major Depressive Disorder
Interventions: Near-infrared radiation via Transcranial LED Therapy, Sham device; Device
Lead sponsor: Paolo Cassano; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Boston, Massachusetts • Chelsea, Massachusetts

Conditions: Pulmonary Embolism, Deep Vein Thrombosis
Interventions: Telephone follow-up; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Blood Donors
Interventions: Motivational Interview, Knowledge Interview; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 1,177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Heart Failure, Congestive Heart Failure
Interventions: RAMP 200, RAMP Reader; Device
Lead sponsor: Response Biomedical Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 719 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 3
States / cities: San Francisco, California • Baltimore, Maryland • Minneapolis, Minnesota

Conditions: Diet Modification, Lung Cancer
Interventions: Special Diet Therapy (low-carb), Special Diet Therapy (low-fat), Special Diet Therapy (USDA control); Behavioral
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Lymphoblastic Leukemia
Interventions: Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine, Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 18 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2022
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pediatric Cancer
Interventions: PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect); Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 3 Years to 11 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Adult Intracranial Neoplasm, Vascular: Intracranial
Interventions: Fluorescein Sodium; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 2
States / cities: Indianapolis, Indiana • Norfolk, Virginia

Search by objective public record fields.

To Compare Two Commonly Used Soft Tissue Grafting Techniques to Achieve Coronal Flap Advancement and Root Coverage

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Effect of Intraoperative Anesthetic Management on Postoperative Nausea and Vomiting in Bariatric Surgery

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects

Limiting Emergence Phenomena After General Anesthesia With Combined LMA and ETT Airway Management Technique

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

How do the Neck Muscles Influence Head Acceleration During Sport-associated Impact Events in High School Athletes?

Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?

SFGH Health Advocates Stage II Study

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Effect of Strength and Coordination Training on Biomechanics and Injury in New Runners

Bisphenol and Phthalate Exposures in Triple Negative Breast Cancer

Transcranial Laser Therapy for Major Depressive Disorder

Outpatient Treatment of PE and DVT in the Emergency Department

A Survey of Attitudes of Experienced Blood Donors

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

Reducing Insulin, Growth Hormones, and Tumors

Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia

Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)

Yellow 560 Microscope for Intraoperative Visualization of Fluorescein Stained Intracranial Lesions